Literature DB >> 22048744

Comprehensive risk reduction in patients with atrial fibrillation: Emerging diagnostic and therapeutic options. Executive summary of the report from the 3rd AFNET/EHRA consensus conference.

Paulus Kirchhof1, Gregory Y H Lip, Isabelle C Van Gelder, Jeroen Bax, Elaine Hylek, Stefan Kääb, Ulrich Schotten, Karl Wegscheider, Giuseppe Boriani, Michael Ezekowitz, Hans Diener, Hein Heidbuchel, Deirdre Lane, Luis Mont, Stephan Willems, Paul Dorian, Panos Vardas, Günter Breithardt, A John Camm.   

Abstract

There are exciting new developments in several areas of atrial fibrillation (AF) management that carry the hope of improving outcomes in AF patients. This paper is an executive summary that summarises the proceedings from the 3rd AFNET/EHRA consensus conference on atrial fibrillation, held in Sophia Antipolis from November 7th to 9th 2010, shortly after the release of the new ESC guidelines on AF. The conference was jointly organised by the German Atrial Fibrillation competence NETwork (AFNET) and the European Heart Rhythm Association (EHRA). This executive summary report covers four sections: 1. Risk factors and risk markers for AF, 2. Pathophysiological classification of AF, 3. Relevance of monitored AF duration for AF-related outcomes, and 4. Perspectives and needs for implementing better antithrombotic therapy.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22048744     DOI: 10.1160/TH11-07-0517

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  18 in total

1.  Increasing use of anticoagulants in Germany and its impact on hospitalization rates for genitourinary bleeding.

Authors:  Olga von Beckerath; Alexander Matthias Paulitschek; Knut Kröger; Bernd Kowall; Frans Santosa; Andreas Stang
Journal:  J Thromb Thrombolysis       Date:  2020-05       Impact factor: 2.300

Review 2.  2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design.

Authors:  Hugh Calkins; Karl Heinz Kuck; Riccardo Cappato; Josep Brugada; A John Camm; Shih-Ann Chen; Harry J G Crijns; Ralph J Damiano; D Wyn Davies; John DiMarco; James Edgerton; Kenneth Ellenbogen; Michael D Ezekowitz; David E Haines; Michel Haissaguerre; Gerhard Hindricks; Yoshito Iesaka; Warren Jackman; Jose Jalife; Pierre Jais; Jonathan Kalman; David Keane; Young-Hoon Kim; Paulus Kirchhof; George Klein; Hans Kottkamp; Koichiro Kumagai; Bruce D Lindsay; Moussa Mansour; Francis E Marchlinski; Patrick M McCarthy; J Lluis Mont; Fred Morady; Koonlawee Nademanee; Hiroshi Nakagawa; Andrea Natale; Stanley Nattel; Douglas L Packer; Carlo Pappone; Eric Prystowsky; Antonio Raviele; Vivek Reddy; Jeremy N Ruskin; Richard J Shemin; Hsuan-Ming Tsao; David Wilber
Journal:  J Interv Card Electrophysiol       Date:  2012-03       Impact factor: 1.900

Review 3.  Atrial fibrillation: state of the art.

Authors:  Matthias Hasun; Eduard Gatterer; Franz Weidinger
Journal:  Wien Klin Wochenschr       Date:  2014-11-20       Impact factor: 1.704

Review 4.  Blood pressure control versus atrial fibrillation management in stroke prevention.

Authors:  Carmine Savoia; Lidia Sada; Massimo Volpe
Journal:  Curr Hypertens Rep       Date:  2015-06       Impact factor: 5.369

Review 5.  Incorporating Stroke and Bleeding Risk Stratification Tools into Atrial Fibrillation Management Making Sense of the Alphabet Soup.

Authors:  Thomas F Deering
Journal:  J Atr Fibrillation       Date:  2017-04-30

6.  CHADS2 and CHA2DS2Vasc-Score in Peripheral Systemic Embolism.

Authors:  Frans Santosa; Thomas Nowak; Theodoros Moysidis; Frank Eickmeier; Christoph Stallinger; Bernd Luther; Kröger Knut
Journal:  J Atr Fibrillation       Date:  2013-06-30

7.  The impact of height on the risk of atrial fibrillation: the Cardiovascular Health Study.

Authors:  Michael A Rosenberg; Kristen K Patton; Nona Sotoodehnia; Maria G Karas; Jorge R Kizer; Peter J Zimetbaum; James D Chang; David Siscovick; John S Gottdiener; Richard A Kronmal; Susan R Heckbert; Kenneth J Mukamal
Journal:  Eur Heart J       Date:  2012-09-12       Impact factor: 29.983

8.  Cranial and non-cranial embolism: incidence in hospitalised patients in Germany.

Authors:  Theodoros Moysidis; Frans Santosa; Christian Stallinger; Knut Kröger
Journal:  J Thromb Thrombolysis       Date:  2013-11       Impact factor: 2.300

9.  Beating-heart Thoracoscopic Left Atrial Appendage Exclusion in a Patient with Left atrial Thrombus.

Authors:  Ali Khoynezhad
Journal:  J Atr Fibrillation       Date:  2017-12-31

Review 10.  Expert consensus document: Defining the major health modifiers causing atrial fibrillation: a roadmap to underpin personalized prevention and treatment.

Authors:  Larissa Fabritz; Eduard Guasch; Charalambos Antoniades; Isabel Bardinet; Gerlinde Benninger; Tim R Betts; Eva Brand; Günter Breithardt; Gabriela Bucklar-Suchankova; A John Camm; David Cartlidge; Barbara Casadei; Winnie W L Chua; Harry J G M Crijns; Jon Deeks; Stéphane Hatem; Françoise Hidden-Lucet; Stefan Kääb; Nikos Maniadakis; Stephan Martin; Lluis Mont; Holger Reinecke; Moritz F Sinner; Ulrich Schotten; Taunton Southwood; Monika Stoll; Panos Vardas; Reza Wakili; Andy West; André Ziegler; Paulus Kirchhof
Journal:  Nat Rev Cardiol       Date:  2015-12-24       Impact factor: 32.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.